Medicare Enrolled
Dr. Sudhir Hansalia, MD
Hematology & Oncology · Trinity, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hansalia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hansalia? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hansalia
Dr. Sudhir Hansalia is a hematology & oncology in Trinity, FL, with 18 years in practice. Based on federal Medicare data, Dr. Hansalia performed 1,966 Medicare services across 688 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hansalia received a total of $18,527 from 91 pharmaceutical and/or device companies across 989 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hansalia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 32% volume in FL$ $18,527 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,966
Medicare services
Top 32% in FL for hematology & oncology
688
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~109 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) | 395 | $8 | $17 |
| Complete blood count (CBC) with differential | 377 | $8 | $25 |
| Office visit, established patient (20-29 min) | 206 | $66 | $219 |
| Drug injection, under skin or into muscle | 164 | $11 | $34 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 112 | $22 | $68 |
| Administration of chemotherapy into vein, 1 hour or less | 101 | $98 | $307 |
| Comprehensive metabolic blood panel | 96 | $10 | $32 |
| Injection, diphenhydramine hcl, up to 50 mg | 88 | $1 | $3 |
| Office visit, established patient (30-39 min) | 78 | $92 | $310 |
| Injection of additional new drug or substance into vein | 76 | $11 | $37 |
| Ferritin level test (iron stores) | 54 | $13 | $34 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 53 | $45 | $151 |
| Vitamin B-12 level test | 44 | $15 | $38 |
| Folic acid level test | 40 | $14 | $37 |
| Lactate dehydrogenase (enzyme) level | 37 | $6 | $15 |
| New patient office visit (45-59 min) | 20 | $112 | $406 |
| Initial hospital admission, high complexity | 13 | $139 | $427 |
| Iron level test | 12 | $6 | $16 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.4% high complexity
21.8% medium
69.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,527
Total received (2018-2024)
Avg $2,647/year across 7 years
Top 27% in FL for hematology & oncology
91
Companies
989
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,873 (96.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$654 (3.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,989
2023$3,200
2022$3,140
2021$2,444
2020$1,635
2019$2,470
2018$2,650
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,252
PFIZER INC.
$1,197
E.R. Squibb & Sons, L.L.C.
$1,043
AstraZeneca Pharmaceuticals LP
$1,008
Janssen Biotech, Inc.
$1,003
Celgene Corporation
$832
Lilly USA, LLC
$825
Incyte Corporation
$570
Seagen Inc.
$568
Daiichi Sankyo Inc.
$547
GENZYME CORPORATION
$449
Merck Sharp & Dohme Corporation
$446
Amgen Inc.
$445
Astellas Pharma US Inc
$431
Gilead Sciences, Inc.
$430
GlaxoSmithKline, LLC.
$394
Bayer HealthCare Pharmaceuticals Inc.
$384
Genentech USA, Inc.
$337
Eisai Inc.
$289
EMD Serono, Inc.
$281
Bayer Healthcare Pharmaceuticals Inc.
$239
Exelixis Inc.
$238
Takeda Pharmaceuticals U.S.A., Inc.
$235
Kite Pharma, Inc.
$231
ARRAY BIOPHARMA INC
$220
Karyopharm Therapeutics Inc.
$205
Boehringer Ingelheim Pharmaceuticals, Inc.
$190
Pharmacyclics LLC, An AbbVie Company
$172
Puma Biotechnology, Inc.
$157
BeiGene USA, Inc.
$148
Alexion Pharmaceuticals, Inc.
$108
Immunomedics, Inc.
$103
Ipsen Biopharmaceuticals, Inc
$101
Fennec Pharmaceuticals, Inc.
$97
Apellis Pharmaceuticals, Inc.
$89
TESARO, Inc.
$85
Pharmacosmos Therapeutics Inc.
$80
Myovant Sciences Inc.
$80
Organon LLC
$76
Tempus AI, Inc
$76
Sobi, Inc
$75
Kyowa Kirin, Inc.
$75
Myriad Genetic Laboratories, Inc.
$73
SOBI, INC
$71
Regeneron Healthcare Solutions, Inc.
$69
EISAI INC.
$64
Janssen Pharmaceuticals, Inc
$62
PharmaEssentia USA Corporation
$61
Merck Sharp & Dohme LLC
$61
Agios Pharmaceuticals, Inc.
$57
Stemline Therapeutics Inc.
$56
AVEO Pharmaceuticals, Inc.
$54
SERVIER PHARMACEUTICALS LLC
$49
Azurity Pharmaceuticals, Inc.
$46
Blueprint Medicines Corporation
$46
TerSera Therapeutics LLC
$46
JAZZ PHARMACEUTICALS INC.
$45
Deciphera Pharmaceuticals Inc.
$44
Rigel Pharmaceuticals, Inc.
$42
AMAG Pharmaceuticals, Inc.
$41
ABBVIE INC.
$40
CTI BioPharma Corp.
$37
Epizyme, Inc.,
$36
Partner Therapeutics, Inc.
$35
Sumitomo Pharma America, Inc.
$33
MEDIVATION FIELD SOLUTIONS LLC
$33
Iovance Biotherapeutics, Inc.
$31
ARGENX US, INC.
$31
Helsinn Therapeutics (U.S.), Inc.
$30
Shire North American Group Inc
$30
PUMA BIOTECHNOLOGY, INC.
$28
GE HealthCare
$26
GE HEALTHCARE
$24
Alnylam Pharmaceuticals Inc.
$23
EUSA Pharma (US) LLC
$22
Sun Pharmaceutical Industries Inc.
$21
Inari Medical, Inc.
$21
Mirati Therapeutics, Inc.
$20
Advanced Accelerator Applications
$20
Jazz Pharmaceuticals Inc.
$19
Aveo Pharmaceuticals, Inc.
$19
Heron Therapeutics, Inc.
$19
Lexicon Pharmaceuticals, Inc.
$18
Verity Pharmaceuticals Inc.
$16
MorphoSys, US Inc.
$16
Spectrum Pharmaceuticals Inc.
$16
Clovis Oncology, Inc.
$14
TAIHO ONCOLOGY, INC.
$14
NOVARTIS PHARMACEUTICALS CORPORATION
$12
Seattle Genetics, Inc.
$12
Dova Pharmaceuticals
$11
Top 3 companies account for 24.2% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · BALVERSA · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · CABLIVI · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Erleada · FARESTON · FASLODEX · FERAHEME · FLOWTRIEVER CATHETER · FOTIVDA · FRUZAQLA · Fabhalta · GAVRETO · GILOTRIF · GIVLAARI · Gazyva · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · JADENU · JAKAFI · JEVTANA · Jivi · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lunsumio · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Pomalyst · QINLOCK · Quzyttir · REBLOZYL · Rezlidhia · Rubraca · S · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TUKYSA · Tibsovo · Trelstar · Trodelvy · ULTOMIRIS · VALCHLOR · VARUBI · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · VYVGART HYTRULO · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xospata · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $942 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
93
Per 100K population
15.8
County median income
$67,384
Nearest hospital
HCA FLORIDA TRINITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hansalia is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hansalia experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Hansalia performed 395 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hansalia receive payments from pharmaceutical companies?
Yes. Dr. Hansalia received a total of $18,527 from 91 companies across 989 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hansalia's costs compare to other hematology & oncologys in Trinity?
Dr. Hansalia's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hansalia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Trinity
Browse hematology & oncologys in Trinity ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology